INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 130 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2015. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $67,000 | -60.8% | 4,398 | 0.0% | 0.01% | -62.1% |
| Q2 2016 | $171,000 | +59.8% | 4,398 | +14.3% | 0.03% | +52.6% |
| Q1 2016 | $107,000 | -6.1% | 3,848 | +80.9% | 0.02% | -5.0% |
| Q4 2015 | $114,000 | +34.1% | 2,127 | 0.0% | 0.02% | +17.6% |
| Q3 2015 | $85,000 | +25.0% | 2,127 | 0.0% | 0.02% | +30.8% |
| Q2 2015 | $68,000 | – | 2,127 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |